Capstone Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Capstone Asset Management's BIIB Position: Q2 2017 in Review
Capstone Asset Management reduced its Biogen (BIIB) stake by 3.1% in Q2 2017, selling an estimated $145K and leaving 17,024 shares worth $4.62M. The position accounts for 0.13% of the portfolio, ranked #194.
Capstone Asset Management first reported a position in BIIB in Q2 2013 and has held it in 17 quarters since. The position peaked at $8.68M in Q3 2013. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.
- Capstone Asset Management held 17,024 shares of Biogen worth $4.62M as of Q2 2017.
- Capstone Asset Management sold 550 Biogen shares in Q2 2017, an estimated $145K.
- Biogen made up 0.13% of Capstone Asset Management's portfolio in Q2 2017, its #194 holding.
- Capstone Asset Management first reported a position in Biogen in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's Biogen position peaked at $8.68M in Q3 2013.
- 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.